1. Home
  2. BSRR vs SPRY Comparison

BSRR vs SPRY Comparison

Compare BSRR & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sierra Bancorp

BSRR

Sierra Bancorp

N/A

Current Price

$39.20

Market Cap

532.1M

Sector

Finance

ML Signal

N/A

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

N/A

Current Price

$4.12

Market Cap

473.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BSRR
SPRY
Founded
1977
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
532.1M
473.4M
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
BSRR
SPRY
Price
$39.20
$4.12
Analyst Decision
Hold
Strong Buy
Analyst Count
5
4
Target Price
★ $43.00
$22.50
AVG Volume (30 Days)
31.0K
★ 1.2M
Earning Date
10-26-2026
11-09-2026
Dividend Yield
★ 2.77%
N/A
EPS Growth
★ 10.28
N/A
EPS
★ 1.72
N/A
Revenue
N/A
★ $84,278,000.00
Revenue This Year
$0.89
$54.14
Revenue Next Year
$3.22
$46.73
P/E Ratio
$22.84
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$26.49
$4.00
52 Week High
$43.13
$13.15

Technical Indicators

Market Signals
Indicator
BSRR
SPRY
Relative Strength Index (RSI) 36.22 39.21
Support Level $38.76 N/A
Resistance Level $39.00 $4.57
Average True Range (ATR) 0.69 0.24
MACD -0.14 0.05
Stochastic Oscillator 10.42 40.00

Price Performance

Historical Comparison
BSRR
SPRY

About BSRR Sierra Bancorp

Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. It offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: